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Abstract
Application of single-cell genomics technologies has revolutionized our approach to study the immune system. Unravelling
the functional diversity of immune cells and their coordinated response is key to understanding immunity. Single-cell tran-
scriptomics technologies provide high-dimensional assessment of the transcriptional states of immune cells and have been
successfully applied to discover new immune cell types, reveal haematopoietic lineages, identify gene modules dictating
immune responses and investigate lymphocyte antigen receptor diversity. In this review, we discuss the impact and appli-
cations of single-cell RNA sequencing technologies in immunology.
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Introduction
Our understanding of the immune system has been advanced
over many centuries through the use of single-cell technologies,
primarily microscopy and flow cytometry. However, the num-
ber of parameters that can be measured simultaneously with
these methodologies is limited and reliant on a priori know-
ledge of which antigens to measure. The advent of next-
generation sequencing to measure transcriptome at single-cell
level has revolutionized our ability to interrogate the immune
system [1]. This has enabled the field to move beyond the trad-
itional cell-type classification based on limited characteristics,
[2] and the averaged gene expression read out of bulk popula-
tions which may conceal biologically significant cellular hetero-
geneity [3, 4]. The intrinsic variation (due to cell cycle or
transcription burst) and the extrinsic variation (due to exposure
to stimuli or contact with other cells), and the interaction
between these factors that cause heterogeneity may not be
amenable to study at bulk population level (Figure 1). Accurate
classification of cell types is paramount to understanding the
functional configuration of the immune system.
Single-cell genomics
Several genomics technologies such as quantitative reverse
transcription PCR (RT-qPCR) and microarray have been adapted
to study gene expression in individual cells [5, 6] (reviewed in
[7]). While these can be cheaper, and RT-qPCR can be more sen-
sitive for targeted sampling, scRNA-seq aims to capture the
whole transcriptome and does not require preselection of target
genes. Single-cell sequencing is a recent technology, but tech-
niques to sequence genome and epigenome have been de-
veloped, such as single-cell chromatin immunoprecipitation
sequencing [8], single-cell DNA adenine methyltransferase
identification (DamID) [9] or single-cell combinatorial indexed
Hi-C (sciHi-C), which captures chromosome conformation [10,
11]. Epigenome analysis at single-cell resolution is limited to
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bisulphite sequencing for methylation status (scBS-seq) and
sequencing transposase-accessible open chromatin (ATAC-seq)
[12, 13] (reviewed in [14, 15]). Single-cell RNA sequencing
(scRNA-seq) is the most advanced method and has gained
wide popularity in recent years. The general principle behind
bulk and single-cell sequencing is similar with respect to
mRNA extraction from single cells followed by conversion into
complementary DNA libraries. However, scRNA-seq has lim-
ited starting RNA material which results in lower mapping
rates and library complexity [16]. Several cell isolation meth-
ods and protocols have been developed; scRNA-seq can be per-
formed on cells in a suspension state but also on fixed, frozen
or cryo-preserved samples [17, 18]. Following tissue dissoci-
ation to generate cell suspension, individual cells can be cap-
tured and processed by droplet/microfluidics technologies
(e.g. 10x Genomics Chromium, Fluidigm C1), or direct isolation
into 96- or 384-well plates, by fluorescence-activated cells
sorting (FACS), micromanipulation using a glass micropipette
or optical tweezers [19]. Several protocols exist to generate
sequencing libraries, which involves reverse transcription and
polymerase chain reaction amplification of the 30 or 50 end or
the full length of mRNA (reviewed in [20]). Utilization of
unique molecular identifiers provides information on original
mRNA copy number, and RNA spike-ins can be used for nor-
malization. Plate-based approaches collect one cell in each
well and importantly provide index flow cytometry informa-
tion for each sorted cell. Droplet scRNA-seq approaches use
beads to capture mRNA with barcoded primers. This enables
high-throughput gene expression measures from high number
of single cells. However, there may be cell capture bias, and
mRNA-capture rate, thus library complexity, is lower than in
plate-based approaches. This means fewer genes can be de-
tected and also that gene detection saturates at approximately
an order of magnitude fewer reads than in plate-based tech-
niques [21]. Finally, because of the high number of cells
sequenced and cost constraints, sequencing is often per-
formed at lower-than-saturation depth. These factors lead to a
higher gene dropout effect, i.e. non-detection of expressed
genes [22]. The advantages and limitations of the different
approaches present various trade-offs between the number of
cells analysed, ability to capture rare cells, library complexity,
depth of sequencing and cost (total and per cell). The scRNA-
seq protocol of choice is therefore guided by the specific re-
search goals (reviewed in [23]). For example, discovering dis-
tinct new rare populations requires surveying a great number
of cells using droplet methods, while characterization of rare
cells requires prior enriching, which can be based on known
surface marker expression [24].
Sequenced reads from single cells are analysed in a similar
manner to bulk-population RNA sequencing data. Reads are
mapped to the reference genome or transcriptome, for which a
variety of programs have been developed, such as STAR, kallisto
or salmon [25–27], but a reference can also be built based on the
data itself. Kallisto and salmon also provide estimation of tran-
script abundance, but several tools, such as HTSeq [28] or
featureCounts [29], provide normalized units, such as TPM,
FPKM/RPKM or raw counts. This step is followed by data normal-
ization, i.e. a correction of unwanted biological and technical ef-
fects, such as sequencing depth, cell cycle stage, gene number
or batch effect, using spike-ins or other statistical techniques
[30]. Quality checks can be performed at several stages, both at
read level, where adapter sequences are trimmed and low-qual-
ity reads are removed, and at the cell level, where cells with low
number of reads, genes or alignment percentage are removed
[31]. Analysis of the prepared transcriptome profiles of thou-
sands of single cells allows detailed investigations of cell diver-
sity and heterogeneity, leading to better characterization of cell
types, decomposition of tissues and even organs [32]. This het-
erogeneity can be explored in multiple ways. First, the data can
be visualized to understand the overall structure. Single-cell
RNA-seq data is multidimensional, therefore visualization
requires using a dimensionality-reduction technique, such as
principal component analysis (PCA), t-distributed stochastic
neighbour embedding (t-SNE) [33], or a diffusion map [34]. This
is followed by clustering cells according to their gene expression
profiles, using data mining techniques, which include K-means
[35], hierarchical [36], density-based or graph clustering (re-
viewed in [23]). It is important to minimize artefacts at the nor-
malization stage, such as the effect of cell cycle stage, which
can confound clustering analysis, and also to ensure that rare
cells are clustered separately to other populations or discovered
with bespoke tools such as RaceID [35] or GiniClust [37]. Finally,
‘marker’ genes can be identified for each cluster, i.e. genes that
are significantly differently expressed in the cluster. These
genes can be used to identify these cells for subsequent valid-
ation and functional characterization, which is performed to
confirm their identity (Figure 2). Analysis of gene sets also
allows to computationally characterize the cells through differ-
ential gene correlation analysis (DGCA) [38] and pathway ana-
lysis (e.g. pathway and gene set overdispersion analysis [39]), or
to infer gene regulatory networks (e.g. PIDC [40], SCENIC [41]).
Additionally, lineage relationships and differentiation
Figure 1: Heterogeneity of single cells within bulk populations. Cells isolated based on limited number of markers using FACS, by micropipette, optical tweezers or
microfluidics, may contain multiple different cell types and cell states (left panel). If these cells are subjected to bulk analysis (squares), their heterogeneity and unique
functions are masked by an average of gene expression signals. If studied individually (single cells), then their distinct activation responses to stimuli, such as cyto-
kines, lipopolysaccharide or bacteria, can be uncovered (right panel). A specific stimulus can have variable effect on cells and leads to different outcome readout for the
population in total. For instance, the rare cells may be early responders, which differentiate and activate other cells via paracrine signalling, or the cell types may re-
spond differently, by cytokine production (cell type 2/round cells) or differentiation.
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trajectories can be reconstructed using bifurcation analysis
tools, such as SCUBA [42] or Wishbone [43], diffusion maps,
pseudo-time ordering of cells based on transcriptome similarity,
with tools such as Wanderlust [44] or Monocle [45], or using
single-cell topological data analysis (scTDA) [46]. Future
approaches, such as the recently published approximate graph
abstraction (AGA), will reconcile clustering and trajectory ana-
lysis to explain both discrete and continuous cell-to-cell vari-
ation [47]. Several toolkits facilitate scRNA-seq data analysis,
such as Scater [48], Seurat [49] or Sincera [50]; however, the
abovementioned software and statistical approaches are still
currently under development and in the exploratory phase, in
contrast to bulk RNA sequencing, where there is a consensus on
analytical approaches.
Immunology in the single-cell sequencing age
The key applications of scRNA-seq in immunology have been to
unravel cellular heterogeneity, cell development and differenti-
ation, haematopoiesis and gene regulatory networks to predict
immune functions.
Cellular heterogeneity
A seminal early study analysing>4000 cells from mouse
spleen to dissect immune cell heterogeneity demonstrated an
scRNA-seq-based classification of CD11c expressing cells [32].
scRNA-seq has since been used to study immune populations
in many species, including human [51]. There are several
general considerations for interpreting and validating findings
from scRNA-seq analysis, in addition to specific considerations
in the context of immune cells. One general consideration is
resolution, i.e. number of genes per cell provided by the differ-
ent scRNA-seq protocols to cluster cells by mRNA expression.
Secondly, whether a transcriptionally unique cluster of cells is a
distinct cell type, a transitory/intermediate cell type or cell
state. Immune cells, even within distinct lineages, e.g. myeloid
or lymphoid, may share expression of many gene modules,
which may not necessarily be because of these cells being
developmentally related. Thirdly, how to verify, isolate and
functionally characterize transcriptionally distinct cell clus-
ters. Fourth, how many individuals need to be profiled using
scRNA-seq to validate cell clusters or are there alternative
strategies that can be deployed to extend the findings reliably
to a bigger population cohort. A recent scRNA-seq analysis
using Smart-seq2 protocol of human blood lineage-MHCIIþ
cells consisting of known blood dendritic cells (DCs) and
monocytes identified several new populations of DCs,
monocytes and a DC progenitor. In this study, transcriptionally
distinct cell clusters were found within what was previously
thought to be a homogenous population. The identity of new
cell clusters was validated by isolating cells based on surface
markers predicted by mRNA expression, followed by scRNA-
seq of isolated cells to validate their transcriptional identity.
This enabled a cost-effective and scalable means of isolating
newly identified cell types for functional characterization and
demonstrating their presence as a stable cell type in a wider study
population. Furthermore, by adaptively sampling peripheral
blood mononuclear cells (PBMCs) using legacy knowledge of sur-
face markers known to identify DCs and monocytes, the authors
could use FACS to enrich for rare populations [52]. In contrast,
scRNA-seq analysis of unselected PBMCs would require high cell
numbers to be analysed to identify rare cell types because of a
higher representation of abundant cell types. In the case of
PBMCs, approximately 90% of profiled cells will be lymphocytes,
10% monocytes and 1% DCs. The study of 68 000 unselected
PBMCs was able to identify several populations of immune cells
but was more challenging for cells found at a frequency<1% [51].
In addition to exploring the overall cell census and dis-
covering new cell types, scRNA-seq analysis can be focused on
small and well-defined subsets. For example, a study of mouse
Th17 cells identified heterogeneity within this population and
uncovered molecular mechanisms regulating their pathogen-
icity [4].
Development and differentiation
scRNA-seq has been applied to study the developmental pro-
gramme undergone by haematopoietic stem cells and down-
stream progenitors into differentiated immune cells [53, 54]
Figure 2: Integrated analysis of the immune system using single-cell RNA-seq. Cells from immune compartments of interest are isolated and analysed by scRNA-seq.
During analysis, cells are grouped (clustered) by transcriptome profile. New and known cell clusters can be further investigated. The identity of clusters and authenti-
city of new cell types can be validated by flow cytometry, RT-qPCR or sequencing of isolated cells. Morphological and functional studies of new cell types or molecules
provide additional biological insights. The new knowledge is integrated into subsequent experimental models.
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(reviewed in [55, 56]). Trajectory analysis has been applied to
this continuous heterogeneity to uncover DC development and
differentiation in mouse [57] and human [58–60]. Trajectory
analysis can be technically challenging, as most models rely on
the researcher identifying the initial progenitor/precursor popu-
lation and adequate representation of cells at all stages of dif-
ferentiation to define the developmental trajectory. Recent
scRNA-seq-based trajectory analysis of haematopoiesis re-
vealed a less hierarchical model of differentiation and early
commitment into distinct lineages [61, 62]. In embryonic haem-
atopoiesis, scRNA-seq revealed the early tissue colonization of
precursors, which subsequently acquire a macrophage tran-
scriptional program and differentiate into tissue-specific
macrophages during organogenesis [63]. The development and
heterogeneity of innate lymphoid cells (ILCs) have also been
investigated [64], providing a new framework for studying these
cells [65, 66]. Trajectory analysis and modelling also recon-
structed the differentiation pathways of naı¨ve CD4þ cells into T
follicular helper (Tfh) and Th1 cells [67].
Immune cell function
Single-cell sequencing, which provides V(D)J transcript data, has
been used to study lymphocyte antigen receptors e.g. T cell recep-
tor (TCR) and B-cell receptor (BCR) sequences. A computational
method, TraCeR, was developed to reconstruct TCR sequences
and reveal clonal relationships between cells. TCR reconstruction
combined with T-cell transcriptional analysis was used to map
T cell activation dynamics in a mouse Salmonella infection model
[68]. Two more recent studies on TCR repertoires developed a
method that can predict epitope-specificity of TCR sequences [69]
and an algorithm, GLIPH (grouping of lymphocyte interactions by
paratope hotspots), that groups T cells by TCR specificity [70].
Carmona et al. analysed evolutionary conservation of genes in
human and mouse immune cell types, which enabled the identifi-
cation of three T cell populations within zebrafish. Using TCR
locus reconstruction, new immune-specific genes, such as novel
immunoglobulin-like receptors, were discovered [71]. Similarly, a
software tool, BASIC (BCR assembly from single cells), was de-
veloped for reconstructing and studying B cell repertoire [72].
Other studies focused on the lymphocyte repertoire have been re-
viewed elsewhere [24, 73–75].
The application of clustered regularly interspaced short pal-
indromic repeat (CRISPR) technology-based perturbations of
genes combined with scRNA-seq (Perturb-seq) has provided a
new way to study transcriptional programs and gene expression
networks, and was used to identify gene targets and cell states
affected by individual perturbations of transcription factors in
bone marrow-derived DCs in response to lipopolysaccharide
[76]. Another similar combined CRISPR-based gene editing with
scRNA-seq study assessed the effect of transcription factors in
mouse haematopoiesis, which revealed a critical role for the
Cebpb gene in monocyte and DC development [77]. Complex
host–pathogen interactions at single-cell level have revealed
new biological insights. Shalek et al. [78, 79] found heterogeneity
in the response of bone marrow-derived DCs to the bacterial
cell wall component, lipopolysaccharide, and showed bimodal
gene expression across cells. Variation in host macrophage re-
sponse to Salmonella was shown to be determined by transcrip-
tional heterogeneity within the infecting bacteria [80, 81]. In
addition, Salmonella growth rate was also discovered to be de-
pendent on macrophage state [82]. Bacterial challenge of macro-
phages was also used in a demonstration of a new massively
parallel scRNA-seq technique termed Seq-Well. In this method,
cells are confined together with beads in subnanoliter wells,
where cell lysis and mRNA capture to beads take place. After es-
tablishing its ability to distinguish between PBMC populations,
the macrophage response to Mycobacterium tuberculosis was
interrogated, and three macrophage sub-phenotypes were iden-
tified in the culture system [83]. A new microfluidic lab-on-a-
chip method, Polaris, enabled investigation of the influence of
the micromilieu on gene expression dynamics using CRISPR-
edited macrophages, and implicated critical roles of SAMHD1 in
tissue-resident macrophages [84].
Several other studies investigated specific aspects of im-
mune cell function. Characterization of mouse Treg heterogen-
eity uncovered their composition and identified a rare subset of
CD43þCCR5þCXCR3 Tregs that express Il10 and Gzmb, which are
responsible for dampening cutaneous immune responses [85].
Ageing was shown to be associated with a diminished ability to
upregulate core transcription modules for effective immune re-
sponses in naive and effector memory CD4þ T cells in mice [54],
and a role for microbiota on epigenetic regulation and gene
expression of ILCs was also recently shown by scRNA-seq
analysis [86].
Cancer immunology
In addition to infectious disease, scRNA-seq has provided new
insights in cancer immunology through comprehensive tumour
and immune cell profiling. Studies that combined single-cell
profiling with tumour spatial heterogeneity analysis have iden-
tified multiple mechanisms of cancer-associated immunosup-
pression, including tumour-infiltrating T cell dysfunction [87]
and immunosuppressive tumoural T cells and macrophages
[88]. Similarly, a study of gene expression diversity in microglia
and macrophages in glioma showed a continuum of microglia-
specific versus macrophage-specific genes, and suggested that
tumour microenvironments alter the gene expression profile of
microglia/macrophages, so that it is dominant over cell origin
[89]. Comparison of tumour with healthy tissue from the same
patient offers insights into the immune landscape during tu-
mour development. In one such study of lung adenocarcinoma,
altered T, natural killer and myeloid cell compartments were
identified, which possibly compromise tumour immunity [90].
Enrichment of tissue homeostatic modules in human melan-
oma DCs and monocytes was another mechanism of cancer
immunomodulation, which was illustrated by single-cell profil-
ing [91]. scRNA-seq analysis of 15 melanomas and additional
2068 tumour-infiltrating T cells revealed spatial and functional
heterogeneity in the tumour and T cells within and between in-
dividuals, and uncovered the range of T cell activation and ex-
haustion programs [92]. Finally, a study involving CD4þ T cells
found that myeloid cell expansion is critical for the control of
malaria parasite (Plasmodium chabaudi) replication and host re-
covery. It established that CD4þ T cells produce macrophage
colony-stimulating factor and that myeloid cell expansion is de-
pendent on these cells [93].
Complementing single-cell sequencing
analysis
Single-cell RNA-seq relies primarily on a deconstructionist
approach, where the analysed cells are dissociated from tis-
sue into suspension format resulting in loss of micro-
anatomical positional information. Combining scRNA-seq
with spatial high-dimensional transcriptomics, imaging and
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single-molecule FISH (fluorescent in situ hybridization), such as
RNA-scope, will aid dissection of functional niches and immune
organisation within tissues (reviewed in [94]). The feasibility of
the spatial transcriptomics approach was demonstrated on the
adult mouse olfactory bulb brain region [95]. Combined strat-
egies have been illuminating in development [96] and cancer
immunology studies [90, 92]. In addition, integrating scRNA-seq
with parallel lncRNA, miRNA and other omics measurements,
such as epigenome, proteome or metabolome, will provide fur-
ther biological and mechanistic insights [97]. Several methods
have been published that measure RNA and protein from the
same cells. These use oligonucleotide probes, which hybridize
to target transcripts and are detected by cytometry (proximity
ligation assay for RNA, PLAYR) [98], or label proteins using
antibody-conjugated oligonucleotides, which are sequenced to-
gether with the transcriptome, providing a readout for a select
number of target proteins (proximity extension assay, PEA [99],
RNA expression and protein sequencing assay, REAP-seq [100]
and cellular indexing of transcriptome and epitopes by
sequencing, CITE-seq [101]). Microfluidics assays have also been
developed to measure secreted proteins and transcriptome sim-
ultaneously [102].
Future perspective
High-dimensional single-cell technologies present a radical de-
parture from classical top-down hypothesis-based research. They
enable a bottom-up unbiased approach with big data generation
followed by hypothesis generation and testing. While high-
dimensional single-cell methods have provided unprecedented
resolution to observe and model biological phenomena, it is crit-
ical to extend the observations made with functional validation
and experimentation to unravel mechanistic biological insights.
This requires a multidisciplinary research team effort to over-
come the convention of using genomics just as a tool, computa-
tion as an analytical means and immunology as a model system,
as the combined expertise will have a greater impact than the
sum of the individual components. This integrated approach will
facilitate biological validation and meaningful experimentation
and analysis of big scRNA-seq data sets. With time, costs associ-
ated with cell preparation and sequencing will decline and will be
accompanied by progress in protocol automation and improve-
ments in technical shortcomings of scRNA-seq, such as the small
number of sequencing reads or the sparsity of data, which cur-
rently pose analytical challenges [103]. These advancements will
increase cell throughput and number of genes that are detected
per cell. With automation and decrease in sequencing cost, an
important experiment design question to be solved is the number
of biological replicates or individuals needed for reliable and gen-
eralizable conclusions.
Multi-omics approaches will provide comprehensive profiles
of epigenome, transcriptome and proteome, and promise to
solve some questions, such as our understanding of cell types,
and the links between the genome and epigenome (reviewed in
[104]). Finally, the integration of omics and screening technolo-
gies, such as Perturb-seq, will facilitate high-throughput experi-
mentation. However, these present considerable experimental
and data analysis challenges [105]. These promising approaches
applied to human experimental model systems and disease set-
tings will facilitate mechanistic rather than descriptive under-
standing. Such mechanistic insights can be used to identify
robust molecular targets for drug and personalized immuno-
therapy strategies.
Key Points
• Single-cell sequencing technologies have revolutionized
our approach to study the immune system.
• Enables high-dimensional dissection of cellular het-
erogeneity and establishes developmental relationships
and functional predictions.
• Future integration with other types of omics data will
expand our understanding of the immune system.
Acknowledgement
The authors would like to thank Dorin-Mirel Popescu for re-
viewing the manuscript.
Funding
This work was supported by the Wellcome Trust (grant
number WT107931/Z/15/Z), the Lister Institute of
Preventative Medicine and the National Institute for Health
Research Newcastle Biomedical Research Centre.
References
1. Proserpio V, Mahata B. Single-cell technologies to study the
immune system. Immunology 2016;147(2):133–40.
2. Vieira Braga FA, Teichmann SA, Chen X. Genetics and im-
munity in the era of single-cell genomics. Hum Mol Genet
2016;25(R2):R141–8.
3. Mahata B, Zhang X, Kolodziejczyk AA, et al. Single-cell RNA
sequencing reveals T helper cells synthesizing steroids de
novo to contribute to immune homeostasis. Cell Rep 2014;
7(4):1130–42.
4. Gaublomme JT, Yosef N, Lee Y, et al. Single-cell genomics
unveils critical regulators of Th17 cell pathogenicity. Cell
2015;163(6):1400–12.
5. Li HH, Gyllensten UB, Cui XF, et al. Amplification and ana-
lysis of DNA sequences in single human sperm and diploid
cells. Nature 1988;335(6189):414–7.
6. Klein CA, Seidl S, Petat-Dutter K, et al. Combined transcrip-
tome and genome analysis of single micrometastatic cells.
Nat Biotechnol 2002;20(4):387–92.
7. Hoppe PS, Coutu DL, Schroeder T. Single-cell technologies
sharpen up mammalian stem cell research. Nat Cell Biol
2014;16(10):919–27.
8. Rotem A, Ram O, Shoresh N, et al. Single-cell ChIP-seq re-
veals cell subpopulations defined by chromatin state. Nat
Biotechnol 2015;33(11):1165–72.
9. Kind J, Pagie L, de Vries SS, et al. Genome-wide maps of nu-
clear lamina interactions in single human cells. Cell 2015;
163(1):134–47.
10. Ramani V, Deng X, Qiu R, et al. Massively multiplex single-
cell Hi-C. Nat Methods 2017;14(3):263–6.
11. Stevens TJ, Lando D, Basu S, et al. 3D structures of individual
mammalian genomes studied by single-cell Hi-C. Nature
2017;544:59–64.
12. Smallwood SA, Lee HJ, Angermueller C, et al. Single-cell
genome-wide bisulfite sequencing for assessing epigenetic
heterogeneity. Nat Methods 2014;11(8):817–20.
13. Buenrostro JD, Giresi PG, Zaba LC, et al. Transposition of na-
tive chromatin for fast and sensitive epigenomic profiling of
open chromatin, DNA-binding proteins and nucleosome
position. Nat Methods 2013;10(12):1213–8.
Single cell transcriptomics in immunology | 5
Downloaded from https://academic.oup.com/bfg/advance-article-abstract/doi/10.1093/bfgp/ely003/4934918
by University of Newcastle user
on 25 June 2018
14. Schwartzman O, Tanay A. Single-cell epigenomics: techniques
and emerging applications.Nat Rev Genet 2015;16(12):716–26.
15. Clark SJ, Lee HJ, Smallwood SA, et al. Single-cell epigenomics:
powerful new methods for understanding gene regulation
and cell identity. Genome Biol 2016;17(1):72.
16. Kolodziejczyk AA, Kim JK, Svensson V, et al. The technology and
biology of single-cell RNA sequencing.Mol Cell 2015;58(4):610.
17. Thomsen ER, Mich JK, Yao Z, et al. Fixed single-cell transcrip-
tomic characterization of human radial glial diversity. Nat
Methods 2016;13(1):87–93.
18. Guillaumet-Adkins A, Rodrı´guez-Esteban G, Mereu E, et al.
Single-cell transcriptome conservation in cryopreserved
cells and tissues. Genome Biol 2017;18:45.
19. Hu P, Zhang W, Xin H, et al. Single cell isolation and analysis.
Front Cell Dev Biol 2016;4:116.
20. Hedlund E, Deng Q. Single-cell RNA sequencing: technical
advancements and biological applications. Mol Aspects Med
2017;59:36–46.
21. Svensson V, Natarajan KN, Ly L-H, et al. Power analysis of
single-cell RNA-sequencing experiments. Nat Methods 2017;
14:381–7.
22. Neu KE, Tang Q, Wilson PC, et al. Single-cell genomics:
approaches and utility in immunology. Trends Immunol 2017;
38(2):140–9.
23. Andrews TS, Hemberg M. Identifying cell populations with
scRNASeq. Mol Aspects Med 2018;59:114–122.
24. Friedensohn S, Khan TA, Reddy ST. Advanced methodolo-
gies in high-throughput sequencing of immune repertoires.
Trends Biotechnol 2017;35(3):203–14.
25. Dobin A, Davis CA, Schlesinger F, et al. STAR: ultrafast uni-
versal RNA-seq aligner. Bioinformatics 2013;29(1):15–21.
26. Bray NL, Pimentel H, Melsted P, et al. Near-optimal probabil-
istic RNA-seq quantification. Nat Biotechnol 2016;34:888.
27. Patro R, Duggal G, Love MI, et al. Salmon provides fast and
bias-aware quantification of transcript expression. Nat
Methods 2017;14(4):417–9.
28. Anders S, Pyl PT, Huber W. HTSeq—a Python framework to
work with high-throughput sequencing data. Bioinformatics
2015;31(2):166–9.
29. Liao Y, Smyth GK, Shi W. FeatureCounts: an efficient general
purpose program for assigning sequence reads to genomic
features. Bioinformatics 2014;30(7):923–30.
30. Vallejos CA, Risso D, Scialdone A, et al. Normalizing single-
cell RNA sequencing data: challenges and opportunities. Nat
Methods 2017;14(6):565–71.
31. Villani AC, Shekhar K. Single-cell RNA sequencing of human
T cells. Methods Mol Biol 2017;1514:203–39.
32. Jaitin DA, Kenigsberg E, Keren-Shaul H, et al. Massively par-
allel single-cell RNA-seq for marker-free decomposition of
tissues into cell types. Science 2014;343(6172):776–9.
33. Maaten L, Hinton G. Visualizing data using t-SNE. J Mach
Learn Res 2008;9:2579–605.
34. Haghverdi L, Buettner F, Theis FJ. Diffusion maps for high-
dimensional single-cell analysis of differentiation data.
Bioinformatics 2015;31(18):2989–98.
35. Grun D, Lyubimova A, Kester L, et al. Single-cell messenger
RNA sequencing reveals rare intestinal cell types. Nature
2015;525(7568):251–5.
36. Patel AP, Tirosh I, Trombetta JJ, et al. Single-cell RNA-seq
highlights intratumoral heterogeneity in primary glioblast-
oma. Science 2014;344(6190):1396–401.
37. Jiang L, Chen H, Pinello L, et al. GiniClust: detecting rare cell
types from single-cell gene expression data with Gini index.
Genome Biol 2016;17(1):144.
38. McKenzie AT, Katsyv I, Song W-M, et al. DGCA: a comprehen-
sive R package for differential gene correlation analysis.
BMC Syst Biol 2016;10(1):106.
39. Fan J, Salathia N, Liu R, et al. Characterizing transcriptional
heterogeneity through pathway and gene set overdispersion
analysis. Nat Methods 2016;13:241–4.
40. Chan TE, Stumpf MPH, Babtie AC. Gene regulatory network
inference from single-cell data using multivariate informa-
tion measures. Cell Syst 2017;5(3):251–67.e253.
41. Aibar S, Gonzalez-Blas CB, Moerman T, et al. SCENIC: single-
cell regulatory network inference and clustering. Nat
Methods 2017;14(11):1083–6.
42. Marco E, Karp RL, Guo G, et al. Bifurcation analysis of single-
cell gene expression data reveals epigenetic landscape. Proc
Natl Acad Sci USA 2014;111(52):E5643–50.
43. Setty M, Tadmor MD, Reich-Zeliger S, et al. Wishbone identi-
fies bifurcating developmental trajectories from single-cell
data. Nat Biotechnol 2016;34(6):637.
44. Bendall SC, Davis KL, Amir eAD, et al. Single-cell trajectory
detection uncovers progression and regulatory coordination
in human B cell development. Cell 2014;157(3):714.
45. Trapnell C, Cacchiarelli D, Grimsby J, et al. The dynamics
and regulators of cell fate decisions are revealed by pseudo-
temporal ordering of single cells. Nat Biotechnol 2014;32(4):
381–6.
46. Rizvi AH, Camara PG, Kandror EK, et al. Single-cell
topological RNA-seq analysis reveals insights into cellular
differentiation and development. Nat Biotechnol 2017;35(6):
551.
47. Wolf FA, Hamey F, Plass M, et al. Graph abstraction recon-
ciles clustering with trajectory inference through a topology
preserving map of single cells. bioRxiv 2017, https://doi.org/
10.1101/208819.
48. McCarthy DJ, Campbell KR, Lun ATL, et al. Scater: pre-
processing, quality control, normalization and visualization
of single-cell RNA-seq data in R. Bioinformatics 2017;33(8):
1179–86.
49. Butler A, Satija R. Integrated analysis of single cell transcrip-
tomic data across conditions, technologies, and species.
bioRxiv 2017, https://doi.org/10.1101/164889.
50. Guo M, Wang H, Potter SS, et al. SINCERA: a pipeline for
single-cell RNA-seq profiling analysis. PLoS Comput Biol 2015;
11(11):e1004575.
51. Zheng GX, Terry JM, Belgrader P, et al. Massively parallel digi-
tal transcriptional profiling of single cells. Nat Commun 2017;
8:14049.
52. Villani AC, Satija R, Reynolds G, et al. Single-cell RNA-seq re-
veals new types of human blood dendritic cells, monocytes,
and progenitors. Science 2017;356.
53. Nestorowa S, Hamey FK, Pijuan Sala B, et al. A single-cell
resolution map of mouse hematopoietic stem and progeni-
tor cell differentiation. Blood 2016;128(8):e20–31.
54. Martinez-Jimenez CP, Eling N, Chen HC, et al. Aging in-
creases cell-to-cell transcriptional variability upon immune
stimulation. Science 2017;355:1433–6.
55. Jaitin DA, Keren-Shaul H, Elefant N, et al. Each cell counts:
hematopoiesis and immunity research in the era of single
cell genomics. Semin Immunol 2015;27(1):67–71.
56. Perie L, Duffy KR. Retracing the in vivo haematopoietic tree
using single-cell methods. FEBS Lett 2016;590:4068–83.
57. Schlitzer A, Sivakamasundari V, Chen J, et al. Identification
of cDC1- and cDC2-committed DC progenitors reveals early
lineage priming at the common DC progenitor stage in the
bone marrow. Nat Immunol 2015;16(7):718–28.
6 | Vegh and Haniffa
Downloaded from https://academic.oup.com/bfg/advance-article-abstract/doi/10.1093/bfgp/ely003/4934918
by University of Newcastle user
on 25 June 2018
58. Breton G, Zheng S, Valieris R, et al. Human dendritic cells
(DCs) are derived from distinct circulating precursors that
are precommitted to become CD1cþ or CD141þ DCs. J Exp
Med 2016;213(13):2861–70.
59. See P, Dutertre CA, Chen J, et al. Mapping the human DC lin-
eage through the integration of high-dimensional tech-
niques. Science 2017;356.
60. Olsson A, Venkatasubramanian M, Chaudhri VK, et al.
Single-cell analysis of mixed-lineage states leading to a bin-
ary cell fate choice. Nature 2016;537(7622):698–702.
61. Drissen R, Buza-Vidas N, Woll P, et al. Distinct myeloid
progenitor-differentiation pathways identified through
single-cell RNA sequencing. Nat Immunol 2016;17:666–76.
62. Paul F, Arkin Y, Giladi A, et al. Transcriptional heterogeneity
and lineage commitment in myeloid progenitors. Cell 2015;
163:1663–7.
63. Mass E, Ballesteros I, Farlik M, et al. Specification of tissue-
resident macrophages during organogenesis. Science 2016;
353(6304):353.
64. Yu Y, Tsang JC, Wang C, et al. Single-cell RNA-seq identifies
a PD-1hi ILC progenitor and defines its development path-
way. Nature 2016;539(7627):102–6.
65. Bjorklund AK, Forkel M, Picelli S, et al. The heterogeneity of
human CD127(þ) innate lymphoid cells revealed by single-
cell RNA sequencing. Nat Immunol 2016;17:451–60.
66. Suffiotti M, Carmona SJ, Jandus C, et al. Identification of in-
nate lymphoid cells in single-cell RNA-seq data.
Immunogenetics 2017;69(7):439–50.
67. Lo¨nnberg T, Svensson V, James KR, et al. Single-cell RNA-seq
and computational analysis using temporal mixture model-
ling resolves Th1/Tfh fate bifurcation in malaria. Sci Immunol
2017;2:eaal2192.
68. Stubbington MJ, Lonnberg T, Proserpio V, et al. T cell fate and
clonality inference from single-cell transcriptomes. Nat
Methods 2016;13(4):329–32.
69. Dash P, Fiore-Gartland AJ, Hertz T, et al. Quantifiable predict-
ive features define epitope-specific T cell receptor reper-
toires. Nature 2017;547(7661):89–93.
70. Glanville J, Huang H, Nau A, et al. Identifying specificity groups
in the T cell receptor repertoire.Nature 2017;547(7661):94–8.
71. Carmona SJ, Teichmann SA, Ferreira L, et al. Single-cell tran-
scriptome analysis of fish immune cells provides insight
into the evolution of vertebrate immune cell types. Genome
Res 2017;27:451–61.
72. Canzar S, Neu KE, Tang Q, et al. BASIC: bCR assembly from
single cells. Bioinformatics 2017;33:425–7.
73. Wong GK, Heather JM, Barmettler S, et al. Immune dysregu-
lation in immunodeficiency disorders: the role of T-cell re-
ceptor sequencing. J Autoimmun 2017;80:1–9.
74. Phetsouphanh C, Zaunders JJ, Kelleher AD. Detecting
antigen-specific T cell responses: from bulk populations to
single cells. Int J Mol Sci 2015;16(12):18878–93.
75. Proserpio V, Lonnberg T. Single-cell technologies are revolu-
tionizing the approach to rare cells. Immunol Cell Biol 2016;
94(3):225–9.
76. Dixit A, Parnas O, Li B, et al. Perturb-Seq: dissecting molecu-
lar circuits with scalable single-cell RNA profiling of pooled
genetic screens. Cell 2016;167(7):1853.
77. Jaitin DA, Weiner A, Yofe I, et al. Dissecting immune circuits
by linking CRISPR-pooled screens with single-cell RNA-seq.
Cell 2016;167(7):1883.
78. Shalek AK, Satija R, Adiconis X, et al. Single-cell transcrip-
tomics reveals bimodality in expression and splicing in im-
mune cells. Nature 2013;498(7453):236–40.
79. Shalek AK, Satija R, Shuga J, et al. Single-cell RNA-seq reveals
dynamic paracrine control of cellular variation. Nature 2014;
510:363–9.
80. Garcia-Del Portillo F, Pucciarelli MG. RNA-Seq unveils new
attributes of the heterogeneous Salmonella-host cell commu-
nication. RNA Biol 2017;14(4):429–35.
81. Avraham R, Haseley N, Brown D, et al. Pathogen cell-to-cell
variability drives heterogeneity in host immune responses.
Cell 2015;162(6):1309–21.
82. Saliba AE, Li L, Westermann AJ, et al. Single-cell RNA-seq ties
macrophage polarization to growth rate of intracellular
Salmonella. Nat Microbiol 2016;2:16206.
83. Gierahn TM, Wadsworth MH, 2nd, Hughes TK, et al. Seq-
Well: portable, low-cost RNA sequencing of single cells at
high throughput. Nat Methods 2017;14(4):395–8.
84. Wills QF, Mellado-Gomez E, Nolan R, et al. The nature and
nurture of cell heterogeneity: accounting for macrophage
gene-environment interactions with single-cell RNA-Seq.
BMC Genomics 2017;18(1):53.
85. Ikebuchi R, Teraguchi S, Vandenbon A, et al. A rare subset
of skin-tropic regulatory T cells expressing Il10/Gzmb in-
hibits the cutaneous immune response. Sci Rep 2016;6(1):
35002.
86. Gury-BenAri M, Thaiss CA, Serafini N, et al. The spectrum
and regulatory landscape of intestinal innate lymphoid cells
are shaped by the microbiome. Cell 2016;166(5):
1231–46.e1213.
87. Singer M, Wang C, Cong L, et al. A distinct gene module for
dysfunction uncoupled from activation in tumor-infiltrating
T cells. Cell 2016;166:1500–11.e1509.
88. Chung W, Eum HH, Lee HO, et al. Single-cell RNA-seq enables
comprehensive tumour and immune cell profiling in pri-
mary breast cancer. Nat Commun 2017;8:15081.
89. Venteicher AS, Tirosh I, Hebert C, et al. Decoupling genetics,
lineages, and microenvironment in IDH-mutant gliomas by
single-cell RNA-seq. Science 2017;355:eaai8478.
90. Lavin Y, Kobayashi S, Leader A, et al. Innate immune land-
scape in early lung adenocarcinoma by paired single-cell
analyses. Cell 2017;169(4):750–65.e717.
91. Nirschl CJ, Suarez-Farinas M, Izar B, et al. IFNgamma-de-
pendent tissue-immune homeostasis is co-opted in the
tumor microenvironment. Cell 2017;170(1):127–41.e115.
92. Tirosh I, Izar B, Prakadan SM, et al. Dissecting the multicellu-
lar ecosystem of metastatic melanoma by single-cell RNA-
seq. Science 2016;352(6282):189.
93. Fontana MF, de Melo GL, Anidi C, et al. Macrophage colony
stimulating factor derived from CD4þ T cells contributes to
control of a blood-borne infection. PLoS Pathog 2016;12:
e1006046.
94. Crosetto N, Bienko M, van Oudenaarden A. Spatially
resolved transcriptomics and beyond. Nat Rev Genet 2015;
16(1):57–66.
95. Stahl PL, Salmen F, Vickovic S, et al. Visualization and ana-
lysis of gene expression in tissue sections by spatial tran-
scriptomics. Science 2016;353(6294):78–82.
96. Satija R, Farrell JA, Gennert D, et al. Spatial reconstruction of
single-cell gene expression data. Nat Biotechnol 2015;33(5):
495.
97. Macaulay IC, Ponting CP, Voet T. Single-cell multiomics:
multiple measurements from single cells. Trends Genet 2017;
33(2):155–68.
98. Frei AP, Bava FA, Zunder ER, et al. Highly multiplexed simul-
taneous detection of RNAs and proteins in single cells. Nat
Methods 2016;13(3):269–75.
Single cell transcriptomics in immunology | 7
Downloaded from https://academic.oup.com/bfg/advance-article-abstract/doi/10.1093/bfgp/ely003/4934918
by University of Newcastle user
on 25 June 2018
99. Genshaft AS, Li S, Gallant CJ, et al. Multiplexed, targeted
profiling of single-cell proteomes and transcriptomes in a
single reaction. Genome Biol 2016;17(1):188.
100. Peterson VM, Zhang KX, Kumar N, et al. Multiplexed quanti-
fication of proteins and transcripts in single cells. Nat
Biotechnol 2017;35(10):936.
101. Stoeckius M, Hafemeister C, Stephenson W, et al.
Simultaneous epitope and transcriptome measurement in
single cells. Nat Methods 2017;14(9):865–8.
102. George J, Wang J. Assay of genome-wide transcriptome and se-
creted proteins on the same single immune cells by microflui-
dics and RNA sequencing.Anal Chem 2016;88(20):10309–15.
103. Yuan GC, Cai L, Elowitz M, et al. Challenges and emerging
directions in single-cell analysis. Genome Biol 2017;18(1):84.
104. Bock C, Farlik M, Sheffield NC. Multi-omics of single cells:
strategies and applications. Trends Biotechnol 2016;34(8):605–8.
105. Lanning BR, Vakoc CR. Single-minded CRISPR screening. Nat
Biotechnol 2017;35(4):339–40.
8 | Vegh and Haniffa
Downloaded from https://academic.oup.com/bfg/advance-article-abstract/doi/10.1093/bfgp/ely003/4934918
by University of Newcastle user
on 25 June 2018
